Next-Generation Biological Fluid Processing Systems
Legal Citation
Summary of the Inventive Concept
A paradigm shift in biological fluid processing, integrating machine learning, wearable technology, and real-time analytics to revolutionize fluid balance monitoring and control.
Background and Problem Solved
The original patent disclosed systems and methods for monitoring and controlling fluid balance in medical procedures, but limitations in real-time data analysis and treatment personalization hindered its potential. The new inventive concept addresses these limitations by introducing advanced technologies to provide more accurate, personalized, and efficient fluid balance management.
Detailed Description of the Inventive Concept
The next-generation biological fluid processing system comprises a machine learning module to predict optimal fluid volumes based on patient medical history and treatment data. A wearable, portable light source for extracorporeal photopheresis enables real-time monitoring and treatment. A nanofiltration module removes unwanted cellular components, and a microfluidic channel analyzes fluid composition in real-time. The system integrates with a database of genomic profiles to predict optimal treatment protocols and provide real-time feedback. In vivo monitoring of fluid balance is achieved through implantable micro-sensors, transmitting data to a remote server for analysis and feedback.
Novelty and Inventive Step
The new inventive concept's integration of machine learning, wearable technology, and real-time analytics provides a novel and non-obvious solution for biological fluid processing, surpassing the original patent's limitations and enabling more accurate, personalized, and efficient fluid balance management.
Alternative Embodiments and Variations
Alternative embodiments may include using different machine learning algorithms, varying the type of wearable technology, or incorporating additional sensors for in vivo monitoring. Variations may also include adapting the system for use in different medical procedures or integrating with other medical devices.
Potential Commercial Applications and Market
The next-generation biological fluid processing system has significant commercial potential in the medical device industry, particularly in the fields of hematology, oncology, and personalized medicine. The system's ability to provide real-time, personalized fluid balance management can improve treatment outcomes, reduce healthcare costs, and enhance patient quality of life.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M1/3607 |
| A | A61 | A61M1/0209 |
| A | A61 | A61M1/361 |
| A | A61 | A61M1/3643 |
| A | A61 | A61M1/3672 |
| A | A61 | A61M1/3683 |
| A | A61 | A61M1/3693 |
| A | A61 | A61M1/3696 |
| A | A61 | A61M1/38 |
| A | A61 | A61M2202/0092 |
| A | A61 | A61M2202/0407 |
| A | A61 | A61M2202/0413 |
| A | A61 | A61M2202/0415 |
| A | A61 | A61M2202/0429 |
| A | A61 | A61M2202/0439 |
| A | A61 | A61M2202/0443 |
| A | A61 | A61M2205/3386 |
| A | A61 | A61M2205/50 |
| A | A61 | A61M2230/005 |
| A | A61 | A61M2230/207 |
Original Patent Information
| Patent Number | US 11,857,714 |
|---|---|
| Title | Systems and methods for monitoring and controlling fluid balance during a biological fluid procedure |
| Assignee(s) | Fenwal, Inc. |